Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Peritoneovenous shunting for refractory ascites results in worsening of nephrotic syndrome.

Takaki A, Maeshima Y, Yagi T, Katayama A, Hinamoto N, Akagi S, Sugiyama H, Tomoda T, Iwasaki Y, Yasunaka T, Ikeda F, Miyake Y, Kobashi H, Hirano A, Makino H, Yamamoto K.

Hepatol Res. 2012 Oct;42(10):1048-53. doi: 10.1111/j.1872-034X.2012.01012.x.

PMID:
22998724
2.

Peritoneovenous shunting restores atrial natriuretic factor responsiveness in refractory hepatic ascites.

Tobe SW, Morali GA, Greig PD, Logan A, Blendis LM.

Gastroenterology. 1993 Jul;105(1):202-7.

PMID:
8514035
3.

Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.

Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.

Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5.

PMID:
14696397
4.

[A case of nephrotic syndrome mimicking membranoproliferative glomerulonephritis (MPGN) and associated with reactive hemophagocytic syndrome after renal death].

Wakabayashi Y, Tsuchida H, Hamaguchi K, Kaito K, Nakano H, Suzuki S, Miura Y, Watanabe S, Kobayashi M, Kawaguchi Y, et al.

Nihon Jinzo Gakkai Shi. 1995 Apr;37(4):253-7. Japanese.

PMID:
7602813
5.

[Two cases of rapidly progressive nephritic syndrome complicated with alcoholic liver cirrhosis].

Kaneko T, Arima R, Arakawa Y, Aoki M, Fukuda K, Fukui M, Hirama A, Fujita E, Mii A, Utsumi K, Shimizu A, Iino Y.

Nihon Jinzo Gakkai Shi. 2011;53(1):60-7. Japanese.

PMID:
21370579
6.

Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.

Ginès P, Arroyo V, Vargas V, Planas R, Casafont F, Panés J, Hoyos M, Viladomiu L, Rimola A, Morillas R, et al.

N Engl J Med. 1991 Sep 19;325(12):829-35.

7.

Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites.

Stanley MM, Ochi S, Lee KK, Nemchausky BA, Greenlee HB, Allen JI, Allen MJ, Baum RA, Gadacz TR, Camara DS.

N Engl J Med. 1989 Dec 14;321(24):1632-8.

PMID:
2586565
8.

Morbidity and mortality after peritoneovenous shunt surgery for refractory ascites.

Rubinstein D, McInnes I, Dudley F.

Gut. 1985 Oct;26(10):1070-3.

9.

Ammonia levels and the severity of hepatic encephalopathy.

Qureshi MO, Khokhar N, Shafqat F.

J Coll Physicians Surg Pak. 2014 Mar;24(3):160-3. doi: 03.2014/JCPSP.160163.

PMID:
24613109
10.

Renal prostaglandin E2 and other vasoactive modulators in refractory hepatic ascites: response to peritoneovenous shunting.

Shaw-Stiffel T, Campbell PJ, Sole MJ, Greig P, Wong PY, Blendis LM.

Gastroenterology. 1988 Nov;95(5):1332-8.

PMID:
3049218
11.

Peritoneovenous shunt as a bridge to liver transplantation.

Dumortier J, Pianta E, Le Derf Y, Bernard P, Bouffard Y, Boucaud C, Sagnard P, Delafosse B, Boillot O.

Am J Transplant. 2005 Aug;5(8):1886-92.

12.

Peritoneovenous shunt for intractable ascites due to hepatic lymphorrhea after hepatectomy.

Inoue Y, Hayashi M, Hirokawa F, Takeshita A, Tanigawa N.

World J Gastrointest Surg. 2011 Jan 27;3(1):16-20. doi: 10.4240/wjgs.v3.i1.16.

13.

Remission of membranoproliferative glomerulonephritis associated with a noncirrhotic portosystemic shunt after percutaneous transhepatic portal vein embolization.

Okamoto N, Fukazawa S, Shimamoto M, Yamamoto R, Fukazawa Y.

NDT Plus. 2009 Jun;2(3):228-32. doi: 10.1093/ndtplus/sfp019. Epub 2009 Feb 16.

14.
15.

Hepatorenal syndrome: reversal by peritoneovenous shunt.

Fullen WD.

Surgery. 1977 Sep;82(3):337-41.

PMID:
888100
16.

[Peritoneovenous shunt in the surgical treatment of ascites in patients with liver cirrhosis].

Utíkal P, Král V, Bachleda P, Klein J.

Rozhl Chir. 1997 Oct;76(10):497-501. Czech.

PMID:
9471741
17.

Splanchnic and systemic hemodynamics in cirrhotic patients with refractory ascites. Effect of peritoneovenous shunting.

Vons C, Hadengue A, Lee SS, Smadja C, Franco D, Lebrec D.

HPB Surg. 1991 Apr;3(4):259-67; discussion 267-9.

18.

Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.

Smith RE, Nostrant TT, Eckhauser FE, Wilson JP, Knol JA, Strodel WE.

Am J Gastroenterol. 1984 Aug;79(8):659-62.

PMID:
6465114
19.
20.

[A case of nephrotic syndrome during TS-1 therapy after resection of rectal cancer and liver metastasis].

Sakagashira M, Yamada Y.

Nihon Jinzo Gakkai Shi. 2014;56(4):538-44. Japanese.

PMID:
24956887
Items per page

Supplemental Content

Write to the Help Desk